We are a team of passionate scientists, doctors and clinicians, driven to bringing promising therapies to light.

ABOUT ANVIRON

About our company, our mission and our team.

OUR PIPELINE

Overview of our pipeline and our science

LATEST NEWS

Latest news releases and investor packages 

shutterstock_1202989183_edited.jpg

We are a growing team of scientists, clinicians, and physicians focused on developing promising therapies for difficult to treat diseases. Join a team that is committed to discovering and providing good medicines that make a difference in peoples lives. 

JOIN OUR TEAM

shutterstock_1647340636_edited.jpg

COMMUNICATIONS

Get regular updates on our company and pipeline

Thanks for submitting!

OUR DRUG PIPELINE

Our pipeline consists of two promising orphan disease product candidates that have demonstrated effectivity in vitro and in vivo.    

ANV120KD for
Kawasaki Disease

A potent stimulator of Fc specific natural regulatory T-Cells resulting in a promising non-steroidal, non-immunosuppresive product candidate to treat vasculitis conditions such as children's Kawasaki Disease 

ANV221 for Pancreatic Cancer

A novel product candidate shown to reduce pancreatic cancer tumor size and metastases (in vivo models) and work synergistically with standard of care therapies.